|
🐜
|
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
10 auth.
M. Paesmans,
J. Sculier,
P. Libert,
G. Bureau,
G. Dabouis,
J. Thiriaux,
...
J. Michel,
O. V. Cutsem,
R. Sergysels,
P. Mommen
|
8 |
1995 |
8
🐜
|
|
🐢
|
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
10 auth.
J. Klastersky,
J. Sculier,
H. Lacroix,
G. Dabouis,
G. Bureau,
P. Libert,
...
M. Richez,
P. Ravez,
G. Vandermoten,
J. Thiriaux
|
7 |
1990 |
7
🐢
|
|
🐜
|
Prognostic factors for patients with small cell lung carcinoma
12 auth.
M. Paesmans,
J. Sculier,
J. Lecomte,
J. Thiriaux,
P. Libert,
R. Sergysels,
...
G. Bureau,
G. Dabouis,
O. V. Cutsem,
P. Mommen,
V. Ninane,
J. Klastersky
|
7 |
2000 |
7
🐜
|
|
🐜
|
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
10 auth.
J. Klastersky,
J. Sculier,
G. Bureau,
P. Libert,
P. Ravez,
G. Vandermoten,
...
J. Thiriaux,
J. Lecomte,
R. Cordier,
G. Dabouis
|
7 |
1989 |
7
🐜
|
|
🐜
|
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
11 auth.
M. Paesmans,
J. Sculier,
P. Libert,
G. Bureau,
G. Dabouis,
J. Thiriaux,
...
J. Michel,
O. V. Cutsem,
R. Sergysels,
P. Mommen,
J. Klastersky
|
6 |
1997 |
6
🐜
|
|
🐜
|
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
15 auth.
J. Sculier,
M. Paesmans,
J. Lecomte,
O. V. Cutsem,
J. Lafitte,
T. Berghmans,
G. Koumakis,
M. Florin,
J. Thiriaux,
J. Michel,
...
V. Giner,
M. Berchier,
P. Mommen,
Vincent Ninane,
J. Klastersky
|
5 |
2001 |
5
🐜
|
|
🐜
|
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer
10 auth.
J. Sculier,
J. Lafitte,
T. Berghmans,
J. Thiriaux,
J. Lecomte,
A. Efremidis,
...
V. Ninane,
M. Paesmans,
P. Mommen,
J. Klastersky
|
5 |
2000 |
5
🐜
|
|
🐜
|
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
10 auth.
J. Sculier,
J. Klastersky,
V. Giner,
G. Bureau,
J. Thiriaux,
G. Dabouis,
...
A. Efremidis,
F. Ries,
M. Berchier,
R. Sergysels
|
5 |
1994 |
5
🐜
|
|
🐜
|
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
13 auth.
J. Sculier,
J. Lafitte,
J. Lecomte,
T. Berghmans,
J. Thiriaux,
M. Florin,
A. Efremidis,
C. Alexopoulos,
P. Recloux,
Vincent Ninane,
...
P. Mommen,
M. Paesmans,
J. Klastersky
|
5 |
2002 |
5
🐜
|
|
🐜
|
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
16 auth.
J. Sculier,
M. Paesmans,
J. Lafitte,
J. Baumöhl,
J. Thiriaux,
O. Van Cutsem,
P. Recloux,
G. Bureau,
M. Berchier,
C. Zacharias,
...
P. Mommen,
T. Bosschaerts,
T. Berghmans,
P. van Houtte,
V. Ninane,
J. Klastersky
|
5 |
1999 |
5
🐜
|
